Jemera, Gregorio H.
HRN: 02-21-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/20/2026
07/27/2026
IVTT
600mg
Q6h
DM FOOT
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes